Movement Alert|Rocket Lab Falls 5.9% in Regular Trading, Piper Sandler Initiates Coverage With Neutral Rating

Market Focus
Jul 16

On July 16, Rocket Lab fell 5.9% in regular trading, trading at $70.31/share, with turnover of $371 million. The decline was triggered by Piper Sandler initiating coverage of the stock with a Neutral rating and an $83 price target.

In its report, Piper Sandler acknowledged that vertically integrated rocket manufacturers possess cost advantages, but noted it is difficult to characterize Rocket Lab's valuation as cheap on a one-year horizon, expressing a cautious stance on current price levels. The $83 target sits well below the FactSet analyst consensus mean target of $119.07. The Neutral rating stands in contrast to the broader analyst community's average Buy recommendation.

Notably, Rocket Lab had accumulated significant short-term gains following its announcement of an $8 billion acquisition of Iridium Communications and Morgan Stanley's bull-case target price increase to $293. CEO Peter Beck also recently disclosed plans to sell 5 million shares valued at approximately $465 million, further weighing on sentiment around elevated valuation levels.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10